Abstract
Introduction Sexually transmitted infections (STIs) are a significant public health concern globally, particularly affecting young women. Early diagnosis and treatment are essential to reducing or stopping the continuous spread of infections and the development of the associated complications. Syndromic management, which is commonly used for STIs, presents several barriers, particularly for young women. This protocol is for a study that aims to understand young women’s preferences for a self-sampling intervention for STI diagnosis by using a Discrete Choice Experiment (DCE).
Methods and analysis The following attributes of a self-sampling intervention were identified through a Nominal Group Technique: accessibility, education, confidentiality, self-sampling method, youth-friendliness, and cost. A pilot study involving 20 participants was conducted to refine the DCE questionnaire. A total of 196 young women from underserved communities will be recruited. The participants will be sampled from communities, stratified by settlement type and socioeconomic status. Data will be analysed using the multinomial logit model and mixed logit model to assess preferences and heterogeneity.
Ethics and dissemination The study findings have the potential to inform policies for STI treatment and management to align healthcare services with user preferences. This can improve STI healthcare access for young women in underserved communities. Ethical approval was obtained, and results will be disseminated through peer-reviewed journals and health conferences.
Strengths and limitations of this study
DCEs provide a platform for users or consumers to express their preference for particular goods or services based on their attribute selection.
Previously STI healthcare service provision has not been aligned with the preferences of young women. Therefore, this will reveal their preferences for a self-sampling intervention for STI healthcare and management.
In instances where user preferences do not align with current practices for STI healthcare, this will provide an opportunity for policies to be reviewed and amended accordingly.
This type of impact on STI healthcare aligns with goal 3.1 of South Africa’s National Strategic Plan which seeks to improve access to healthcare services for STIs and other diseases (1). It also aligns with goal three of the United Nations which seeks to improve access to healthcare for all and thus achieve universal healthcare coverage (2, 3).
Since our study will be conducted on young women residing in underserved urban populations, our findings may not be a true reflection of young women from diverse communities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Faculty of Health Sciences (University of Pretoria) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
no additional data available.
